RT Journal Article SR Electronic T1 Modeling the Spring 2020 New York City COVID-19 Epidemic: New Criteria and Methods for Prediction JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.06.12.20130005 DO 10.1101/2020.06.12.20130005 A1 Barlow, D. A. A1 Baird, J. K. YR 2020 UL http://medrxiv.org/content/early/2020/06/16/2020.06.12.20130005.abstract AB We report here on results obtained using the SIR epidemic model to study the spring 2020 COVID-19 epidemic in New York City (NYC). An approximate solution is derived for this non-linear system which is then used to derive an expression for the time to maximum infection. Additionally, expressions are obtained for estimating the transmission and recovery parameters using data collected in the first ten days of the epidemic. Values for these parameters are then generated using data reported for the spring 2020 NYC COVID-19 epidemic which are then used to estimate the time to maximum infection and the maximum number of infected. Complete details are given so that the method can be used in the event of future epidemics. An additional result of this study is that we are able to suggest a unique mitigation strategy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:There was no lab or clinical activity of any type in this work. It was a theoretical study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in this report is either listed in the report or can be found at the link below. http://www1.nyc.gov/site/doh/covid/covid-19-data.page